Palatin Technologies
PTN
#10903
Rank
ยฃ8.83 M
Marketcap
ยฃ4.96
Share price
-3.60%
Change (1 day)
-48.82%
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -ยฃ6.29 Million

According to Palatin Technologies's latest financial reports the company's current earnings are ยฃ13.18 Million. In 2025 the company made an earning of -ยฃ7.27 Million, an increase over its 2024 earnings that were of -ยฃ20.35 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ6.29 Million-13.56%
2025 -ยฃ7.27 Million-64.29%
2024 -ยฃ20.35 Million-16.9%
2023 -ยฃ24.49 Million5.99%
2022 -ยฃ23.11 Million-13.7%
2021 -ยฃ26.77 Million33.25%
2020 -ยฃ20.09 Million-172.11%
2019 ยฃ27.85 M2352.33%
2018 ยฃ1.13 M-94.13%
2017 ยฃ19.35 M-154.92%
2016 -ยฃ35.25 Million3.67%
2015 -ยฃ34 Million878%
2014 -ยฃ3.48 Million-72.64%
2013 -ยฃ12.71 Million-33.11%
2012 -ยฃ19 Million77.71%
2011 -ยฃ10.69 Million
2003 -ยฃ18.1 Million29.93%
2002 -ยฃ13.93 Million36.18%
2001 -ยฃ10.23 Million
1999 -ยฃ8.49 Million6.04%
1998 -ยฃ8.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ14.14 B-223,736.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ11.39 B-180,349.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.65 B-10,409.19%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-ยฃ8.12 Million 28.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ46 M-827.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-ยฃ88.87 Million 1,305.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
ยฃ0.11 B-1,985.50%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-ยฃ22.28 Million 252.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-ยฃ41.74 Million 560.06%๐Ÿ‡บ๐Ÿ‡ธ USA